Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Canton Strategic Holdings, Inc.THAR · Entity 6394 | Director · Executive Chairman · 10% owner | November 03, 2025 | November 06, 2025 |
| Hepion Pharmaceuticals, Inc.HEPA · Entity 8208 | Director · Executive Chairman | September 03, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Canton Strategic Holdings, Inc.
Report date November 03, 2025 · Filed November 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.08 · Expires 2035-11-03 | Direct | 190,000 |
Reported balance
After 2025-11-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-03 · Grant · Acquired 90,000 · Balance 190,000 |
Hepion Pharmaceuticals, Inc.
Report date September 03, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.06 · Expires 2031-09-03 | IndirectBy Gravitas Capital LP | 22,500,000 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Purchase · Acquired 12,500,000 · Balance 22,500,000 F1: Warrant is only exercisable upon stockholder approval of an increase in the authorized shares of the Company's Common Stock. F2: Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity. |
Filing footnotes · ownership attribution and instrument terms
F1: Warrant is only exercisable upon stockholder approval of an increase in the authorized shares of the Company's Common Stock.
F2: Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 14, 2026 10:30 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseWarrants · Derivative | 12,500,000 | $0.00 Strike: $0.06 | $0.00 |
DisclosureSEC source: 0001493152-26-042470 · ownership.xml · derivative · entry 1 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · By Gravitas Capital LP Disclosed balance after: 22,500,000 Underlying: Common Stock · 12,500,000 shares Expires 2031-09-03 F1 · derivative.exercise_date: Warrant is only exercisable upon stockholder approval of an increase in the authorized shares of the Company's Common Stock. F2 · ownership.nature: Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:34 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | GrantStock Options · Derivative | 1,345,500 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0001493152-26-039702 · ownership.xml · derivative · entry 1 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,345,500 Underlying: Common Stock · 1,345,500 shares Expires 2036-08-19 F1 · derivative.exercise_date: 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant. Read SEC document |
| August 03, 2026 Filed Aug 13, 2026 01:34 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseWarrants · Derivative | 2,000,000 | $0.00 Strike: $0.06 | $0.00 |
DisclosureSEC source: 0001493152-26-037489 · ownership.xml · derivative · entry 4 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · By Invictus Capital Advisors Pension Plan Disclosed balance after: 10,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2031-08-03 F2 · ownership.nature: Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity. Read SEC document |
| August 03, 2026 Filed Aug 13, 2026 01:34 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseWarrants · Derivative | 8,000,000 | $0.00 Strike: $0.06 | $0.00 |
DisclosureSEC source: 0001493152-26-037489 · ownership.xml · derivative · entry 3 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · By Gravitas Capital LP Disclosed balance after: 8,000,000 Underlying: Common Stock · 8,000,000 shares Expires 2031-08-03 F1 · ownership.nature: Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity. Read SEC document |
| August 03, 2026 Filed Aug 13, 2026 01:34 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseCommon Stock | 2,000,000 | $0.05 | $100,000.00 |
DisclosureSEC source: 0001493152-26-037489 · ownership.xml · nonDerivative · entry 2 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · By Invictus Capital Advisors Pension Plan Disclosed balance after: 16,250,000 F2 · ownership.nature: Mr. LoPriore is the trustee and beneficiary of the Invictus Capital Advisors Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity. Read SEC document |
| August 03, 2026 Filed Aug 13, 2026 01:34 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseCommon Stock | 8,000,000 | $0.05 | $400,000.00 |
DisclosureSEC source: 0001493152-26-037489 · ownership.xml · nonDerivative · entry 1 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · By Gravitas Capital LP Disclosed balance after: 14,250,000 F1 · ownership.nature: Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity. Read SEC document |
| April 21, 2026 Filed Apr 27, 2026 10:24 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseCommon Stock, par value $0.0001 per share | 1,250,000 | $0.04 | $50,000.00 |
DisclosureSEC source: 0001493152-26-019029 · ownership.xml · nonDerivative · entry 2 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Invictus Capital Advisors Pension Plan Disclosed balance after: 6,250,000 F2 · ownership.nature: Mr. LoPriore is the trustee and beneficiary of the Pension Plan and in such capacity has the right to vote and dispose of the securities held by such entity. Read SEC document |
| April 21, 2026 Filed Apr 27, 2026 10:24 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseCommon Stock, par value $0.0001 per share | 5,000,000 | $0.04 | $200,000.00 |
DisclosureSEC source: 0001493152-26-019029 · ownership.xml · nonDerivative · entry 1 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Gravitas Capital LP Disclosed balance after: 5,000,000 F1 · ownership.nature: Mr. LoPriore is the Managing Member of Gravitas Capital LP and in such capacity has the right to vote and dispose of the securities held by such entity. Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 01:57 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | GrantStock Option · Derivative | 90,000 | $0.00 Strike: $3.08 | $0.00 |
DisclosureSEC source: 0001493152-25-020939 · ownership.xml · derivative · entry 1 LoPriore Vincent S · CIK 0001633927 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 90,000 shares Expires 2035-11-03 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.